Activation of peripheral δ opioid receptors eliminates cardiac electrical instability in a rat model of post-infarction cardiosclerosis via mitochondrial ATP-dependent K+ channels

L. N. Maslov, Yu B. Lishmanov, N. V. Solenkova, G. J. Gross, G. B. Stefano, S. W. Tam

Результат исследований: Материалы для журналаСтатья

19 Цитирования (Scopus)

Выдержка

The effects of the selective delta-1 (δ1) opioid receptor agonist, DPDPE, and the selective δ2 opioid receptor agonist, DSLET, have been studied on the ventricular fibrillation threshold (VFT) in rats with an experimental post-infarction cardiosclerosis (CS). It has been found that CS induced a significant decrease in VFT. This CS-induced decrease in VFT was significantly reversed by intravenous administration of DPDPE (0.1 mg/kg) 10 min before VFT measurement. On the contrary, intravenous injection of DSLET (0.5 mg/kg) exacerbated the CS-induced cardiac electrical instability. Pretreatment with the selective δ opioid receptor antagonist, ICI 174,864 (0.5 mg/kg), completely abolished the changes in VFT produced by both DPDPE and DSLET. Previous administration of a nonselective peripherally acting opioid receptor antagonist, naloxone methiodide (5 mg/kg) also completely reversed the antifibrillatory action of DPDPE. Naloxone methiodide and ICI 174,864 alone had no effect on VFT. Pretreatment with the nonselective KATP channel blocker, glibenclamide (0.3 mg/kg), or with the mitochondrial selective KATP channel blocker, 5-hydroxydecanoic acid (5-HD, 5 mg/kg), completely abolished the DPDPE-induced increase in cardiac electrical stability. Glibenclamide and 5-HD alone had no effect on VFT. These results demonstrate that the δ opioid receptor plays an important role in the regulation of electrical stability in rats with post-infarction cardiosclerosis. We propose that peripheral δ1 opioid receptor stimulation reverses CS-induced electrical instability via mitochondrial KATP channels. On the contrary, δ2 opioid receptor stimulation may exacerbate the CS-induced decrease in VFT. Further studies are necessary to determine the δ opioid receptor subtype which mediates the antifibrillatory effect of DPDPE and pro-fibrillatory effect of DSLET.

Язык оригиналаАнглийский
Страницы (с-по)947-952
Число страниц6
ЖурналLife Sciences
Том73
Номер выпуска7
DOI
СостояниеОпубликовано - 4 июл 2003

Отпечаток

enkephalin, Ser(2), Leu(5), Thr(6)-
D-Penicillamine (2,5)-Enkephalin
Opioid Receptors
Ventricular Fibrillation
Infarction
Rats
Adenosine Triphosphate
Chemical activation
KATP Channels
Narcotic Antagonists
Glyburide
mitochondrial K(ATP) channel
Intravenous Injections
Intravenous Administration

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Pharmacology, Toxicology and Pharmaceutics(all)

Цитировать

Activation of peripheral δ opioid receptors eliminates cardiac electrical instability in a rat model of post-infarction cardiosclerosis via mitochondrial ATP-dependent K+ channels. / Maslov, L. N.; Lishmanov, Yu B.; Solenkova, N. V.; Gross, G. J.; Stefano, G. B.; Tam, S. W.

В: Life Sciences, Том 73, № 7, 04.07.2003, стр. 947-952.

Результат исследований: Материалы для журналаСтатья

@article{8defc7893dc84f0f94fc1382f3514fd7,
title = "Activation of peripheral δ opioid receptors eliminates cardiac electrical instability in a rat model of post-infarction cardiosclerosis via mitochondrial ATP-dependent K+ channels",
abstract = "The effects of the selective delta-1 (δ1) opioid receptor agonist, DPDPE, and the selective δ2 opioid receptor agonist, DSLET, have been studied on the ventricular fibrillation threshold (VFT) in rats with an experimental post-infarction cardiosclerosis (CS). It has been found that CS induced a significant decrease in VFT. This CS-induced decrease in VFT was significantly reversed by intravenous administration of DPDPE (0.1 mg/kg) 10 min before VFT measurement. On the contrary, intravenous injection of DSLET (0.5 mg/kg) exacerbated the CS-induced cardiac electrical instability. Pretreatment with the selective δ opioid receptor antagonist, ICI 174,864 (0.5 mg/kg), completely abolished the changes in VFT produced by both DPDPE and DSLET. Previous administration of a nonselective peripherally acting opioid receptor antagonist, naloxone methiodide (5 mg/kg) also completely reversed the antifibrillatory action of DPDPE. Naloxone methiodide and ICI 174,864 alone had no effect on VFT. Pretreatment with the nonselective KATP channel blocker, glibenclamide (0.3 mg/kg), or with the mitochondrial selective KATP channel blocker, 5-hydroxydecanoic acid (5-HD, 5 mg/kg), completely abolished the DPDPE-induced increase in cardiac electrical stability. Glibenclamide and 5-HD alone had no effect on VFT. These results demonstrate that the δ opioid receptor plays an important role in the regulation of electrical stability in rats with post-infarction cardiosclerosis. We propose that peripheral δ1 opioid receptor stimulation reverses CS-induced electrical instability via mitochondrial KATP channels. On the contrary, δ2 opioid receptor stimulation may exacerbate the CS-induced decrease in VFT. Further studies are necessary to determine the δ opioid receptor subtype which mediates the antifibrillatory effect of DPDPE and pro-fibrillatory effect of DSLET.",
keywords = "Cardiosclerosis, Delta opioid receptors, K channels, Rat, Ventricular fibrillation threshold",
author = "Maslov, {L. N.} and Lishmanov, {Yu B.} and Solenkova, {N. V.} and Gross, {G. J.} and Stefano, {G. B.} and Tam, {S. W.}",
year = "2003",
month = "7",
day = "4",
doi = "10.1016/S0024-3205(03)00348-5",
language = "English",
volume = "73",
pages = "947--952",
journal = "Life Sciences",
issn = "0024-3205",
publisher = "Elsevier Inc.",
number = "7",

}

TY - JOUR

T1 - Activation of peripheral δ opioid receptors eliminates cardiac electrical instability in a rat model of post-infarction cardiosclerosis via mitochondrial ATP-dependent K+ channels

AU - Maslov, L. N.

AU - Lishmanov, Yu B.

AU - Solenkova, N. V.

AU - Gross, G. J.

AU - Stefano, G. B.

AU - Tam, S. W.

PY - 2003/7/4

Y1 - 2003/7/4

N2 - The effects of the selective delta-1 (δ1) opioid receptor agonist, DPDPE, and the selective δ2 opioid receptor agonist, DSLET, have been studied on the ventricular fibrillation threshold (VFT) in rats with an experimental post-infarction cardiosclerosis (CS). It has been found that CS induced a significant decrease in VFT. This CS-induced decrease in VFT was significantly reversed by intravenous administration of DPDPE (0.1 mg/kg) 10 min before VFT measurement. On the contrary, intravenous injection of DSLET (0.5 mg/kg) exacerbated the CS-induced cardiac electrical instability. Pretreatment with the selective δ opioid receptor antagonist, ICI 174,864 (0.5 mg/kg), completely abolished the changes in VFT produced by both DPDPE and DSLET. Previous administration of a nonselective peripherally acting opioid receptor antagonist, naloxone methiodide (5 mg/kg) also completely reversed the antifibrillatory action of DPDPE. Naloxone methiodide and ICI 174,864 alone had no effect on VFT. Pretreatment with the nonselective KATP channel blocker, glibenclamide (0.3 mg/kg), or with the mitochondrial selective KATP channel blocker, 5-hydroxydecanoic acid (5-HD, 5 mg/kg), completely abolished the DPDPE-induced increase in cardiac electrical stability. Glibenclamide and 5-HD alone had no effect on VFT. These results demonstrate that the δ opioid receptor plays an important role in the regulation of electrical stability in rats with post-infarction cardiosclerosis. We propose that peripheral δ1 opioid receptor stimulation reverses CS-induced electrical instability via mitochondrial KATP channels. On the contrary, δ2 opioid receptor stimulation may exacerbate the CS-induced decrease in VFT. Further studies are necessary to determine the δ opioid receptor subtype which mediates the antifibrillatory effect of DPDPE and pro-fibrillatory effect of DSLET.

AB - The effects of the selective delta-1 (δ1) opioid receptor agonist, DPDPE, and the selective δ2 opioid receptor agonist, DSLET, have been studied on the ventricular fibrillation threshold (VFT) in rats with an experimental post-infarction cardiosclerosis (CS). It has been found that CS induced a significant decrease in VFT. This CS-induced decrease in VFT was significantly reversed by intravenous administration of DPDPE (0.1 mg/kg) 10 min before VFT measurement. On the contrary, intravenous injection of DSLET (0.5 mg/kg) exacerbated the CS-induced cardiac electrical instability. Pretreatment with the selective δ opioid receptor antagonist, ICI 174,864 (0.5 mg/kg), completely abolished the changes in VFT produced by both DPDPE and DSLET. Previous administration of a nonselective peripherally acting opioid receptor antagonist, naloxone methiodide (5 mg/kg) also completely reversed the antifibrillatory action of DPDPE. Naloxone methiodide and ICI 174,864 alone had no effect on VFT. Pretreatment with the nonselective KATP channel blocker, glibenclamide (0.3 mg/kg), or with the mitochondrial selective KATP channel blocker, 5-hydroxydecanoic acid (5-HD, 5 mg/kg), completely abolished the DPDPE-induced increase in cardiac electrical stability. Glibenclamide and 5-HD alone had no effect on VFT. These results demonstrate that the δ opioid receptor plays an important role in the regulation of electrical stability in rats with post-infarction cardiosclerosis. We propose that peripheral δ1 opioid receptor stimulation reverses CS-induced electrical instability via mitochondrial KATP channels. On the contrary, δ2 opioid receptor stimulation may exacerbate the CS-induced decrease in VFT. Further studies are necessary to determine the δ opioid receptor subtype which mediates the antifibrillatory effect of DPDPE and pro-fibrillatory effect of DSLET.

KW - Cardiosclerosis

KW - Delta opioid receptors

KW - K channels

KW - Rat

KW - Ventricular fibrillation threshold

UR - http://www.scopus.com/inward/record.url?scp=0037836012&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037836012&partnerID=8YFLogxK

U2 - 10.1016/S0024-3205(03)00348-5

DO - 10.1016/S0024-3205(03)00348-5

M3 - Article

C2 - 12798419

AN - SCOPUS:0037836012

VL - 73

SP - 947

EP - 952

JO - Life Sciences

JF - Life Sciences

SN - 0024-3205

IS - 7

ER -